Barbeau Pharma Inc.
Records under this name other than patents Barbeau Pharma Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 5 of 5 · Back to Barbeau Pharma Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,989,452 | Stable Hydrazalazine Pharmaceutical Compositions Formerly held Term ended Term ended Oct 9, 2026 · High confidence | Term ended | Term ended Oct 9, 2026 | High confidence |
| US 7,220,858 | Synthesis of Hydrazine and Chlorinated Derivatives of Bicyclic Pyridazines Formerly held Term ended Term ended Nov 6, 2024 · High confidence | Term ended | Term ended Nov 6, 2024 | High confidence |
| US 6,821,974 | Stable pharmaceutical compositions Term ended Term ended Mar 5, 2022 · USPTO record | Term ended | Term ended Mar 5, 2022 | USPTO record |
| US 6,825,196 | Stable pharmaceutical compositions Lapsed on the fee record Ended Nov 30, 2012 · USPTO record | Lapsed on the fee record | Ended Nov 30, 2012 | USPTO record |
| US 7,358,271 | Sulpiride pharmaceutical compositions Formerly held Lapsed on the fee record Ended Apr 15, 2012 · USPTO record | Lapsed on the fee record | Ended Apr 15, 2012 | USPTO record |